Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forbes Health Summit: How Patient Groups Are Changing Biotech
Forbes
Tuesday, February 5, 2013 - 10:59am
tags:
biotech, patients
Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product
Yahoo
Tuesday, February 5, 2013 - 10:58am
tags:
FDA, Warner Chilcott, ulcerative colitis, Delzicol
Allergan misses in quarter, but 2013 view tops forecasts
Reuters
Tuesday, February 5, 2013 - 10:56am
tags:
earnings, Allergan
Taro Provides Third Quarter and Fiscal Year to Date Results
Yahoo
Tuesday, February 5, 2013 - 10:56am
tags:
Taro, earnings
Everybody Wins If Endo Health Is Acquired By Warner Chilcott Or Valeant
Seeking Alpha
Tuesday, February 5, 2013 - 10:54am
tags:
Endo Health Solutions, M&A, Warner Chilcott, Valeant Pharmaceuticals
Incyte Pharmaceuticals Is Primed For A Run
Seeking Alpha
Tuesday, February 5, 2013 - 10:54am
tags:
Incyte, Novartis, Eli Lilly, Jakafi
Forest Laboratories Goes Off Lexapro - What Happens Next?
Seeking Alpha
Tuesday, February 5, 2013 - 10:52am
tags:
Forest Labs, Lexapro
Bayer, J&J Sign Partner Deal With Portola for Xarelto Antidote
Bloomberg
Tuesday, February 5, 2013 - 10:51am
tags:
JNJ, Bayer, Portola, Xarelto, PRT4445
Protalix rallies following report of takeover talks
Yahoo/Fly on the Wall
Tuesday, February 5, 2013 - 10:50am
tags:
Protalix, M&A, Pfizer
Alas, Hamlet! A Diabetes Drugmaker to Renew the Faith
Motley Fool
Tuesday, February 5, 2013 - 10:49am
tags:
diabetes, Novo Nordisk
Gilead Earnings Blaze a Star-Studded Future
Motley Fool
Tuesday, February 5, 2013 - 10:39am
tags:
earnings, Gilead
Idenix Pharma ends development of 2 hepatitis C drugs after regulators signal further holds
Yahoo/AP
Tuesday, February 5, 2013 - 10:38am
tags:
Idenix, hepatitis C, IDX184, IDX19368
3 Things to Watch at Momenta Pharmaceuticals
Motley Fool
Tuesday, February 5, 2013 - 10:34am
tags:
Momenta
Pipeline Progress at Glaxo
Yahoo/Zacks
Tuesday, February 5, 2013 - 10:33am
tags:
GSK, dabrafenib, melanoma
Sanofi's New Diabetes Play Moves Forward
Motley Fool
Tuesday, February 5, 2013 - 10:30am
tags:
Sanofi, diabetes, Lyxumia, GLP-1 agonist
A Closer Look At Keryx Biopharmaceuticals' Phase III Result Announcement
Seeking Alpha
Tuesday, February 5, 2013 - 10:28am
tags:
Keryx, kidney disease, Zerenex
FDA approves generic version of cancer drug Doxil
Reuters
Tuesday, February 5, 2013 - 10:27am
tags:
FDA, generics, Doxil, Sun Pharma, JNJ, ovarian cancer, Multiple Myeloma
Feds grab Shire's attention on Adderall marketing
Fierce Pharma
Monday, February 4, 2013 - 12:23pm
tags:
Shire, Adderall, ADHD
American consumers approach court to consider recall of Ranbaxy's generic drug Lipitor
Economic Times, India
Monday, February 4, 2013 - 12:22pm
tags:
generics, Ranbaxy, Lipitor, Pfizer, recalls
No Sunshine On Continuing Medical Education?
Pharmalot
Monday, February 4, 2013 - 12:21pm
tags:
physicians, CME, Physician Payment Sunshine Act

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.